Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000033874Phase 4Not yet recruiting
Phase 4, randomised trial of retinyl palmitate in Graves Orbitopathy (GO) and dry eye syndrome (DED) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Basal lacrimal secretion, Tear film break-up time and 1 more. Planned start Jun 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000033874.